Thalidomide, the drug that was banned worldwide in the 2018s after it produced a generation of babies with missing and stunted limbs, took a step toward government approval Friday when a committee of scientific advisers recommended that the food and Drug Administration make it available to leprosy patients, but with tight restrictions.
Thalidomide wins support as leprosy treatment.